Interface Biologics Announces New V.P., Business Development

Ontario Industry Updates
Written by Guest User

Interface Biologics announced the addition of Kelley Dealhoy to the IBI management team, as Vice President of Business Development.

Click here to read more

Guest User
Previous

BrainFx Developing Tool for Roadside Detection of Cannabis Impairment
Next

OBIO 2018 Annual General Meeting: Recap and Photo Gallery